API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
Impressions: 927
https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2023-merck-s-keytruda-emerges-as-top-selling-drug-novo-lilly-sales-skyrocket-due-to-glp-1-drugs
Impressions: 2721
https://www.pharmacompass.com/radio-compass-blog/company-tracker-pfizer-turns-to-acquisitions-as-covid-products-sales-nosedive
Impressions: 2222
https://www.pharmacompass.com/radio-compass-blog/dmf-submissions-rise-12-1-in-2022-india-sees-10-6-drop-in-type-ii-filings
Impressions: 2625
https://www.pharmacompass.com/radio-compass-blog/america-s-drug-price-hike-conundrum-in-backdrop-of-2019-medicare-part-d-data
Impressions: 54773
https://www.pharmacompass.com/radio-compass-blog/top-drugs-and-pharmaceutical-companies-of-2019-by-revenues
Impressions: 4700
https://www.pharmacompass.com/radio-compass-blog/us-market-offers-niche-opportunities-reveals-manufacturer-sales-data-from-medicare-part-d
Impressions: 58452
https://www.pharmacompass.com/radio-compass-blog/top-drugs-by-sales-in-2017-who-sold-the-blockbuster-drugs
Impressions: 2497
https://www.pharmacompass.com/radio-compass-blog/fda-announces-generic-drug-user-fees-for-fy18-gilead-acquires-kite-for-us-12-billion
Impressions: 2699
https://www.pharmacompass.com/radio-compass-blog/investors-up-ante-against-mylan-board-more-ipca-products-banned-from-the-us
Impressions: 9295
https://www.pharmacompass.com/radio-compass-blog/chemical-entities-shine-in-the-top-10-fastest-growing-drugs-of-2016
Impressions: 2987
https://www.pharmacompass.com/radio-compass-blog/more-bad-news-engulfs-teva-india-to-bring-laws-so-that-doctors-prescribe-generics
Impressions: 4469
https://www.pharmacompass.com/radio-compass-blog/us-dmf-filings-indicate-a-robust-api-industry-with-multiple-first-to-file-challenges
Impressions: 56562
https://www.pharmacompass.com/radio-compass-blog/top-drugs-by-sales-revenue-in-2015-who-sold-the-biggest-blockbuster-drugs
Impressions: 8789
https://www.pharmacompass.com/radio-compass-blog/the-next-generic-attack-brilinta-ticagrelor-xarelto-rivaroxaban-tradjenta-linagliptin-and
Impressions: 12781
https://www.pharmacompass.com/radio-compass-blog/who-has-the-biggest-one-sales-of-the-top-pharma-products-by-revenue
Impressions: 5030
https://www.pharmacompass.com/radio-compass-blog/fondaparinux-an-opportunity-worth-developing